Dagens industri: SensoDetect Company News

Dagens Industri's reporting on medtech company SensoDetect focuses on both legal and business developments. The coverage details ongoing insider trading allegations involving a Carnegie banker and SensoDetect's former chairman in connection with a Chinese agreement, as well as a separate investigation into another business leader for similar suspected offenses. An earlier investigation concerning current chairman Johan Möllerström was dropped. Beyond the legal challenges, Dagens Industri highlights key business activities. SensoDetect recently appointed Per-Anders Hedin as the new CEO and signed a non-binding letter of intent to acquire assets from Globopetz. Financial reports indicate substantial quarterly losses of several million kronor, accompanied by minimal to no revenue. Furthermore, the coverage includes updates on potential collaborations, including ongoing discussions with a hospital in Saudi Arabia.